Serge Évrard
Serge Évrard publishes mostly in Surgery, Oncology and Pulmonary and Respiratory Medicine, on topics such as Hepatocellular Carcinoma Treatment and Prognosis, Colorectal Cancer Treatments and Studies and Colorectal Cancer Surgical Treatments.
- World rank
- #1,723,498 of 7,710,434 ranked researchers
- Rank in France
- #76,204 of 324,115
- Works
- 310
- Citations
- 3.8k
- Citations per work
- 12.3
What does Serge Évrard research?
Serge Évrard's work is mostly in Medicine (64%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences19964.1%
- Medicine19964.1%
- Everything else11135.9%
- 1Surgery19% of their works
- 2Oncology18% of their works
- 3Pulmonary and Respiratory Medicine9% of their works
- 4Hepatology9% of their works
- 5Epidemiology5% of their works
- 6Radiology, Nuclear Medicine and Imaging5% of their works
Research topics
- Hepatocellular Carcinoma Treatment and Prognosis
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Intraperitoneal and Appendiceal Malignancies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Pancreatic and Hepatic Oncology Research
- Radiomics and Machine Learning in Medical Imaging
- Gastric Cancer Management and Outcomes
Which keywords describe Serge Évrard's research?
The keywords of their largest research topics: Clinical Practice Guidelines, Chemotherapy, Precision Medicine, Hepatocellular Carcinoma, Liver Cancer, Neoadjuvant Therapy, Cetuximab and KRAS Mutations.
- Molecular Characterization
- Surgical Complications
- Pancreatic Cancer
- Cholangiocarcinoma
- Intraperitoneal Chemotherapy
- Rectal Cancer
- Survival Analysis
- KRAS Mutations
- Neoadjuvant Therapy
- Hepatocellular Carcinoma
- Chemotherapy
- Clinical Practice Guidelines
- Precision Medicine
- Liver Cancer
- Cetuximab
- Gastric Cancer
- Preoperative Chemoradiotherapy
- Cytoreductive Surgery
- Biliary Tract Cancer
- Medical Imaging
- Radiomics
- Endoscopic Resection
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Clinical Practice Guidelines953 topics
- Chemotherapy693 topics
- Precision Medicine552 topics
- Hepatocellular Carcinoma531 topic
- Liver Cancer531 topic
- Neoadjuvant Therapy432 topics
- Cetuximab401 topic
- KRAS Mutations401 topic
- Gastric Cancer352 topics
- Survival Analysis352 topics
- Preoperative Chemoradiotherapy281 topic
- Rectal Cancer281 topic
- Cytoreductive Surgery211 topic
- Intraperitoneal Chemotherapy211 topic
- Biliary Tract Cancer191 topic
- Cholangiocarcinoma191 topic
- Medical Imaging151 topic
- Pancreatic Cancer151 topic
- Radiomics151 topic
- Surgical Complications151 topic
- Endoscopic Resection141 topic
- Molecular Characterization141 topic
Where does Serge Évrard work?
Serge Évrard's main affiliation in the publication record is Institut Bergonié, France.
How many publications and citations does Serge Évrard have?
OpenAlex counts 310 works and 3,813 citations for Serge Évrard, an h-index of 36, ranking #1,723,498 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Serge Évrard
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Serge Évrard. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.